Beste Rheumatology podcasts (2025)

1
Ep 48: Approaching eye involvement in rheumatic diseases 30:25

8d ago30:25

30:25

In this podcast, join Dr Stephanie Gall (Rheumatology Registrar) with her guest Dr Nima Ghadiri, a consultant Medical Ophthalmologist at the National Behçet's Centre of Excellence (Liverpool). In this episode, common eye presentations to rheumatology clinics are covered, including discussions regarding ophthalmic manifestations of rheumatic disease…

1
Ryan Hum on synovial immunopathology in psoriatic arthritis 26:48

23d ago26:48

26:48

In today's episode, Sophie discusses psoriatic arthritis with Dr Ryan Hum from The University of Manchester. Psoriatic arthritis affects between 0.1% and 1% of the general population globally, and appears to be more prevalent in certain regions. It affects men and women equally and typically appears between the ages of 30 and 55 years. Psoriatic ar…

1
BONUS CASE: Fever and high ferritin 46:21

1M ago46:21

46:21

Pip Watson ( BSR Education committee chair) chats with Dr Jessica Manson, Dr Michael Wood and Stella Kotsiopoulou. These experts from rheumatology, haeamatology and infectious disease discuss their approach to the management of the unwell patient presenting with fever and a high ferritin. Other resources: Spotlight on HLH - https://www.rheumatology…

1
Scott Uhlrich on personalised gait retraining for knee osteoarthritis 16:26

2M ago16:26

16:26

In this episode, we’re tackling a condition that affects over 374 million people worldwide—knee osteoarthritis (OA). As the most common site of OA, knee OA is a leading cause of disability and accounts for more than 12 million disability-adjusted life years globally. With prevalence rising steadily due to aging populations and increasing obesity ra…

1
E127: TNFs and All That CHF 21:46

2M ago21:46

21:46

Another episode looking into safety this week! Tackling that pesky issue of TNFs and CHF. Be sure to subscribe to my newsletter and check out the papers below! Newsletter: https://sprw.io/stt-ee87b4 ATTACH: https://pubmed.ncbi.nlm.nih.gov/12796126/ RENEWAL: https://www.ahajournals.org/doi/10.1161/01.cir.0000124490.27666.b2 Observational Studies: ht…

1
E126: Risk Signals, JAKs, and SELECTIVE-ity 14:34

2M ago14:34

14:34

Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do JAKs cause all the badness?" questions, but ultimately landing me about where I have been since ORAL-SURVEILLANCE was published Paper: https://www.sciencedirect.com/science/article/pii/S00034967244230…

1
BONUS CASE: Myalgia, muscle weakness and statins 45:55

2M ago45:55

45:55

In this pod Consultant Rheumatologist, Dr Judith Jade, chats with Dr Fergus To, Rheumatologist from British Columbia, about the case of a woman who presented with subacute muscle weakness. They discuss how to approach these types of cases systemically with some handy tips along the way. Listen in and see if you can work out what the diagnosis is! R…

1
Mark Hancock on low back pain 10:20

3M ago10:20

10:20

In this episode, we'll be discussing an issue that affects millions of people globally - low back pain. We will find out why the burden of low back pain is so high, why current management is so ineffective, what we can do from a research and care perspective to improve outcomes for patients, and whether prevention is the way forward. We’ll also dis…

1
Ep 51. Infliximab vs interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial 8:54

3M ago8:54

8:54

In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s. Listen now to hear the findings and what this means for future clinical practice! Fu…

1
BONUS CASE: A tricky case of chest pain that kept coming back 31:33

3M ago31:33

31:33

In this bonus case episode, Dr Roz Benson talks to Dr Nicola Heyer about an interesting case of chest pain that kept returning, can you work out what's going on? References: Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Refe…

1
Vibeke Strand on polymyalgia rheumatica 11:32

4M ago11:32

11:32

In this episode Professor Vibeke Strand discusses polymyalgia rheumatica (or PMR), a common inflammatory rheumatic disease that significantly impairs patients’ quality of life, causing fatigue, pain, and physical disability, especially in relapsing cases that often require long-term glucocorticoid treatment. However, these treatments come with cons…

1
Ep 47: A spotlight on relapsing polychondritis 41:18

4M ago41:18

41:18

Dr Yik Man speaks with Dr Marcela Ferrada about relapsing polychondritis. She brings a unique perspective to the discussion as both expert patient and rheumatologist. Typical clinical presentations to the future research agenda are covered and they even touch on VEXAS - a must listen. Reference - https://www.nature.com/articles/s41584-024-01113-9 T…

1
E125: Adrenal Insufficiency after Stopping Prednisone 17:52

5M ago17:52

17:52

Interesting read this week - I cover a nifty little paper that presented data about adrenal insufficiency after stopping prednisolone, published in JAMA Open in March 2025. Open Access Journal Here: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2831668Door Michael Putman

1
Xue Li on access to biologics in the Asia-Pacific region 19:31

5M ago19:31

19:31

This is a joint podcast between The Lancet Rheumatology and The Lancet Regional Health - Western Pacific with Prof Xue Li. Biologics have become a mainstay of treatment in Rheumatology in Western populations, but in many parts of Asia, especially lower-and-middle-income countries, there remains substantial inequity in access due to differences in a…

1
Sinisa Savic on treatment outcomes in VEXAS syndrome 12:07

5M ago12:07

12:07

In this podcast, Professor Savic talks about his recent publication that looks at treatment outcomes in patients with VEXAS syndrome, as well as what clinicians should look out for in patients (red flags), and future priorities for research. VEXAS syndrome (short for Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome) was first descr…

1
Ep 30. GUIDELINES - BSR management recommendations for ANCA-associated vasculitis 2025 23:11

5M ago23:11

23:11

BSR has published a new set of management recommendations for ANCA-associated vasculitis (AAV), serving as an update to our AAV guideline last published in 2017. Find out more via our blog. Join guideline working group Chair, Lorraine Harper, and group members Rosemary Hollick, Harold Wilson-Morkeh, Georgina Ducker and expert by experience member, …

1
e124: MTX vs Pred for Pulmonary Sarcoidosis: PREDMETH Study 14:18

5M ago14:18

14:18

Interesting NEJM trial this week comparing methotrexate to prednisone for pulmonary sarcoidosis. Paper available here: https://www.nejm.org/doi/full/10.1056/NEJMoa2501443Door Michael Putman

1
Ep 50. Modifiable risk factors and therapeutic targets in polymyalgia rheumatica 10:10

5M ago10:10

10:10

How can we identify modifiable risk factors and new therapeutic targets in polymyalgia rheumatica? In this episode, recorded live at BSR25, Prof Ernest Choy and Dr Steven Zhao discuss Steven's genome-wide meta-analysis and Mendelian randomisation study. They cover the key findings, which include some novel loci and potential therapeutic targets for…

1
Fabian Müller and Melanie Hagen on a newly discovered toxicity of CD-19 targeting CAR T-cell therapy 20:50

5M ago20:50

20:50

This is the third and final episode of our mini-series on cell-based therapies in rheumatology, with Professor Fabian Müller and Dr Melanie Hagen from the Erlangen University, Germany. We discuss their recently published a study on a newly discovered toxicity of CD-19 targeting CAR T-cell therapy in patients with autoimmune disease, as well as the …

1
BONUS EPISODE: Mental health and burnout in the rheumatology MDT 42:15

6M ago42:15

42:15

This Talking Rheumatology Spotlight pod on burnout and mental health was recorded live at the BSR Annual Conference 2025. Pip Watson is joined by Gail Kinman (Professor of Occupational Health Psychology), Muzaffer Kaser (Consultant Psychiatrist) and Jacqui Clinch (Consultant Paediatric Rheumatologist and former Vice President of BSR). Burnout is a …

1
Ep 46: The Immunology of Lupus 45:00

6M ago45:00

45:00

Join Dr Mariele Gatto in conversation with Dr Chris Wincup as they discuss all things related to lupus immunology, from pathogenesis to treatment decisions. Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @RheumatologyUK. BSR is the UK's leading specialist medical society for rheumatology and…

1
Ep 49. Improving time to diagnosis in axial spondyloarthritis 11:33

6M ago11:33

11:33

How can we improve time from symptom onset to axSpA diagnosis? In this episode, Dr Fabian Proft talks to Dr Antoni Chan about his fantastic work to reduce time to diagnosis in axial spondyloarthritis (axSpA) using an integrated referral and education system. They discuss the importance of a multi-pronged approach to education, as well as how clinic…

1
Ep 45: Immunology in the virtual biologics clinic 34:10

6M ago34:10

34:10

How do we approach a patient with rheumatic diseases who have cycled through multiple high cost drugs? In this pod, Dr Roz Benson, BSR Digital Learning Editor chats with Dr Arti Mahto, a consultant rheumatologist. They talk through some challenging cases discussed in the virtual biologics clinic and the role of the MDT in complex decision making. T…

1
E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA 18:13

7M ago18:13

18:13

Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449Door Michael Putman

1
Dominique Farge on allogeneic umbilical cord-derived mesenchymal stromal cells for systemic lupus erythematosus 26:05

7M ago26:05

26:05

This is the second episode of a mini series on cell-based therapies in rheumatology, with Prof. Dominique Farge discussing the use of allogeneic umbilical cord-derived mesenchymal stromal cells (MSCs) as treatment for systemic lupus erythematosus (SLE). We cover the limited options currently available for people with severe or refractory SLE, the c…

1
E122: Guidelines for Maybe Diagnosing HLH 11:18

7M ago11:18

11:18

This week I cover another of my newsletters, though I mostly use it as a skeleton to riff on a common (and challenging) issue for rheumatology consultants; diagnosing HLH. Check out the guidelines themselves here and have a listen to the podcast! https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(23)00273-4/fulltext…

1
5.15 Final Results and Thank You 9:09

7M ago9:09

9:09

In this episode, we recap the final results of RheumMadness 2025 and say thank you to our may contributors. If you haven't already, complete our RheumMadness 2025 post-survey here: https://duke.qualtrics.com/jfe/form/SV_1H1cHULbm0R1XWS To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.…

1
Ep 29. GUIDELINES - BSR axial spondyloarthritis guideline 2025 20:31

7M ago20:31

20:31

BSR has published an update to the axial spondyloarthritis guideline. It's almost 10 years since the last iteration of the guideline. Our understanding and awareness of the disease has increased enormously. We now have 10 different therapies licensed for advanced management of axial spondyloarthritis, which are broadly divided into three different …

1
E121: Obinutuzumab in SLE-LN 18:14

7M ago18:14

18:14

Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965Door Michael Putman

1
5.14 Round 1 Reactions 33:02

7M ago33:02

33:02

In this episode, we breakdown our reactions to the first round of RheumMadness 2025, plus we reveal which teams the participants liked the most in their brackets. To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @…

1
BONUS CASE: Muscle weakness 19:55

8M ago19:55

19:55

In this bonus case based episode Dr Steph Gall from the BSR digital learning board discusses an interesting case of muscle weakness with Dr Lisa Waters a Consultant in Rheumatology and Acute Medicine from Manchester. Can you work out what's going on? Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or twe…

1
5.13 Submit Those Brackets! 2:46

8M ago2:46

2:46

Reminder to Submit your brackets by March 31, 2025 at 11:59pm ET! Link to the RheumMadness OnePager by Dr. Mithu Maheswaranathan (@MithuRheum) To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.so…

1
Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease 18:30

8M ago18:30

18:30

The first episode of a mini series on cell-based therapies in rheumatology, with Prof Rebecca Marsh and Grant Schulert discussing the use of allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease. Read the full article: https://www.thelancet.com/journals/la…

1
Ep 28. GUIDELINES - BSR foot health in inflammatory arthritis guideline 15:20

8M ago15:20

15:20

BSR has published a new guideline for the assessment and management of foot problems in adults, children and young people with inflammatory arthritis. Foot problems are almost universal in people with inflammatory arthritis, and virtually all people with inflammatory arthritis will experience foot problems at some point in the course of their disea…

1
5.12 Bracketology 26:21

8M ago26:21

26:21

In this episode, the RheumMadness leadership team discusses our approach to RheumMadness bracketology, including our favorites, dark horses, and read on the Blue Ribbon Panel. Submit your brackets by March 31, 2025 at 11:59pm ET! To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.e…

1
Ep 27. INNOVATORS - Improving care for prisoners in the rheumatology clinic 45:18

8M ago45:18

45:18

Roz Benson (digital learning editor) talks to consultant rheumatologist Dr Lizzy MacPhie and Resident doctor Nouran Abdou about a recent project digging deep into the reasons prisoners face difficulty in accessing care in the rheumatology clinic. This excellent project showcases how quality improvement can be a tool in helping to approach and reduc…

1
5.11 More Panelists Plus CAR-Ts in NephMadness 54:13

8M ago54:13

54:13

In this episode, we introduce the rest of the Blue Ribbon Panel and interview our friends from NephMadness about their CAR-T region. Remember, RheumMadness brackets are open through March 31 at 11:59pm ET! Submit your brackets here. First time playing RheumMadness? Check out our new explainer video! Blue Ribbon Panelists in this episode: Anastasiya…

1
E120: Real Life Use of PEXIVAS-Low 24:33

8M ago24:33

24:33

What do you do when observational data and RCTs conflict? This week I'm covering the "real world PEXIVAS" study that was done by the French Vasculitis Study Group. Great read, interesting issues, have a listen and be sure to share with friends!Door Michael Putman

1
5.10 The Blue Ribbon Panel 33:20

8M ago33:20

33:20

In this episode, we introduce 2 of our fantastic Blue Ribbon Panel members. Their full bios are listed below. You'll meet the rest of the panel in the next episode! Also, RheumMadness brackets are open through March 31 at 11:59pm ET! Submit your brackets here. First time playing RheumMadness? Check out our new explainer video! Panelists in this pod…

1
Ep 44: Fatigue and how to help patients, including insights from the LIFT trial 29:08

8M ago29:08

29:08

In this podcast, Jess Little, specialist MSK physiotherapist, talks to Professor Neil Basu, academic Rheumatologist and Professor Lorna Paul, professor of allied health science about fatigue and particularly what we can do to help patients. It covers everything from the importance to patients of considering fatigue to interventions including the ro…

1
Ep 43: Fatigue in children, adolescents and young people 37:28

8M ago37:28

37:28

In this podcast, Kathryn Rigler, Rheumatology specialist physiotherapist, talks to Poppy Greenman, Paediatric occupational therapist, covering how to talk to children and young people about fatigue, measuring fatigue and strategies to overcome it, with practical tips from an expert in this area Thanks for listening to Talking Rheumatology! Join the…

1
5.9 B-Cell Breakaway Part 2 29:21

9M ago29:21

29:21

In this episode we are joined by some amazing collaborators from the EMEUNET to talk about the STRAP trials. Links to the B-Cell Breakaway Scouting Reports: Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship Program CD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship Program…

1
Bryant England on advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease 8:30

9M ago8:30

8:30

Dr Bryant England discusses the use of TNF-inhibitor versus non-TNF inhibitor biological or targeted synthetic DMARDs for treatment of rheumatoid arthritis-associated ILD, and the effects on survival and respiratory hospitalisation outcomes. Read the full article: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00265-0/fulltext?d…

1
5.8 B-Cell Breakaway 48:26

9M ago48:26

48:26

In this episode we discuss obinutuzumab for lupus nephritis and anti-CD19 CAR T Cell therapy for autoimmune rheumatic disease. Links to the B-Cell Breakaway Scouting Reports: Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship Program CD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology …

1
5.7 Full Court Care Champions Part 2 17:05

9M ago17:05

17:05

In this episode we present part 2 of our conversation about the teams in the Full Court Care Champions region of RheumMadness 2025! Links to the Full Court Care Champions Scouting Reports: Cost-effectiveness of hydroxychloroquine retinopathy screening, by residents from the Lankenau Medical Center Internal Medicine Residency Program Steroid dose in…

1
E119: Teclistamab for Rheumatology Writ Large 10:52

9M ago10:52

10:52

One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell depletion than rituximab" strategies. Article: https://www.nejm.org/doi/full/10.1056/NEJMc2407150…

1
5.6 Full Court Care Champions 31:43

9M ago31:43

31:43

In this episode we dive into the teams in the Full Court Care Champions region of RheumMadness 2025! Links to the Full Court Care Champions Scouting Reports: Cost-effectiveness of hydroxychloroquine retinopathy screening, by residents from the Lankenau Medical Center Internal Medicine Residency Program Steroid dose in lupus nephritis, by the Washin…

1
Ep 42: A tricky case of ILD 41:05

9M ago41:05

41:05

Dr Ashely Elliot speaks to respiratory consultant Dr Nazia Chaudhuri about interstitial lung disease. This overview covers everything from diagnosing CTD- ILD and an evidenced based management approach to poor prognostic risk factors. Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @Rheumatol…

1
E118: The emerging risk of overdiagnosis in RA and PMR 16:02

9M ago16:02

16:02

Podcast this week about overdiagnosis! Currently one of my favorite topics and something that I think will be an emerging issue in our field. We recently published a Viewpoint in Lancet Rheumatology (https://pubmed.ncbi.nlm.nih.gov/39341221/) addressing this issue. I'm going to read from it and after that will be giving a few final (spicy) thoughts…

1
5.5 Cytokine Crushers Part 2 29:28

10M ago29:28

29:28

This episode contains part 2 of our conversation with Michael Macklin, MD, PharmD, Assistant Professor of Medicine at the University of Chicago, about the Cytokine Crushers region of RheumMadness 2025. In this episode, we focus specifically on the TYK2 in SLE and Oral Anti-IL23 teams. Links to the Cytokine Crushers Scouting Reports: Oral anti-IL23,…

Podcasts die het beluisteren waard zijn

Rheumatology Podcasts

Podcasts die het beluisteren waard zijn

Korte handleiding